subscribeSubscribe
Zydus Life hits 52-week high on USFDA nod for Sacubitril and Valsartan

Zydus Life hits 52-week high on USFDA nod for Sacubitril and Valsartan
ECONOMIC TIMES
11 Jul 2024
Share Share
Zydus Pharms Generic Sacubitril :Valsartan Receives Approval in US

Zydus Pharms Generic Sacubitril :Valsartan Receives Approval in US

FDA
09 Jul 2024
Share Share
Amneal`s Generic Valsartan & Hydrochlorothiazide Receives Approval in the U.S.

Amneal`s Generic Valsartan & Hydrochlorothiazide Receives Approval in the U.S.
FDA
11 Aug 2023
Share Share
Novartis heart drug price may fall by 60% on generic rollouts

Novartis heart drug price may fall by 60% on generic rollouts
ECONOMIC TIMES
19 Jan 2023
Share Share
Dr Reddy`s cuts price of cardiovascular drug Cidmus

Dr Reddy`s cuts price of cardiovascular drug Cidmus
ECONOMIC TIMES
19 Jan 2023
Share Share
HC reserves order on Natco`s plea over patent for Novartis drug

HC reserves order on Natco`s plea over patent for Novartis drug
ECONOMIC TIMES
11 Jan 2023
Share Share
Novartis pays $245M to settle Exforge generic pay-for-delay suit

Novartis pays $245M to settle Exforge generic pay-for-delay suit
Angus Liu FIERCE PHARMA
04 Jan 2023
Share Share
Top Novartis cardiac drug to go off patent

Top Novartis cardiac drug to go off patent
ECONOMICTIMES
03 Dec 2022
Share Share
IOL Chemicals secures patent for invention related to preparation of Sartan drugs

IOL Chemicals secures patent for invention related to preparation of Sartan drugs
BUSINESS-STANDARD
27 Nov 2022
Share Share
Prompted by recent recalls, regulators scramble to address novel nitrosamines

Prompted by recent recalls, regulators scramble to address novel nitrosamines
Joanne S. Eglovitch RAPS
31 Oct 2022
Share Share